1. Report Overview
1.1 World Vaccine Contract Manufacturing Market Highlights
1.2 Why You Should Read This Report?
1.3 How This Report Delivers
1.4 Key Questions Answered by This Analytical Report
1.5 Who is This Report For?
1.6 Methodology
1.7 Associated Visiongain Reports
1.8 Frequently Asked Questions (FAQ)
2. Introduction to Vaccines
2.1 The History of Vaccines
2.2 How Do Vaccines Work?
2.2.1 Artificial Immunity
2.3 Types of Vaccine
2.3.1 Live, Attenuated Vaccines (LAVs)
2.3.2 Recombinant Live Vaccines
2.3.3 Inactivated Vaccines
2.3.4 Toxoid Vaccines
2.3.5 Subunit Vaccines
2.3.6 Conjugate Vaccines
2.3.7 Recombinant Subunit Vaccines
2.3.8 DNA Vaccines
2.3.9 Recombinant Vector Vaccines
2.3.10 Therapeutic Vaccines
2.4 Diseases Preventable with Vaccines
2.5 The Rise of the Vaccines Market
2.6 Technological and Regulatory Improvements
3. Vaccine Manufacturing Technologies, 2018
3.1 Summary of Vaccine Technology Trends
3.2 New Substrates for Vaccine Production
3.2.1 Shift towards Cell-Based Manufacturing Technology
3.2.2 Benefits of Cell-Based Techniques
3.2.3 Mammalian Cell Lines
3.2.3.1 Madin Darby Canine Kidney Cells (MDCK)
3.2.3.2 Vero Cells
3.2.3.3 PerC6 Cells
3.2.4 Avian-Derived Cell Lines
3.2.4.1 EB66 Stem Cell Technology: Vivalis
3.2.5 Plant-Based Vaccines
3.2.5.1 Medicago's Proficia VLP Vaccine Technology
3.2.6 Insect Egg-Based Production Systems
3.2.6.1 Novavax
3.2.6.2 Protein Sciences Corporation (PSC)
3.3 Next-Generation Expression Systems and Vectors: Increasing Production Yield
3.3.1 AdVac Technology: Crucell
3.3.2 AdCEV Vectors: AfriVax
3.3.3 Pfenex Expression Technology: Pfenex
3.4 Equipment Trends
3.4.1 The Shift Towards Disposable Single-use Equipment
3.4.2 Bioreactors and Vaccine Production
3.4.2.1 Single-Use Bioreactors
3.4.2.2 Main Applications of Disposable Bioreactors
3.4.2.3 Current Single-Use Bioreactor Systems in the Market
3.5 Prefilled Syringes and Vaccines
3.5.1 Growing Market for Pre-Filled Syringes
3.5.2 Pre-Filled Vaccine Products
3.5.3 Drivers and Restraints for Pre-Filled Syringes
3.5.4 Product Stability and Quality Assurance Programme
3.5.4.1 Paediatric H1N1 Vaccine
3.5.4.2 Reported Challenges Flu Vaccines
3.5.4.3 Novartis' Agriflu and Fluad Ban is Lifted
3.5.4.4 Baxter Flu Vaccine and Side Effects
3.5.4.5 Reported Shelf Life with H1N1 Vaccine
3.6 Lyophilisation and Vaccine Manufacturing
3.6.1 Lyophilisation of Vaccines Will Increase
3.7 Cell Media Can Improve Virus Yield
4. The Global Vaccine Manufacturing Market 2019-2029
4.1 Overview of the Global Vaccine Manufacturing Market 2019-2029
4.2 World Vaccine Market Forecast 2019-2029
4.3 The Global Vaccine Market by Submarket, 2018 and 2019
4.4 Growth in Vaccine Market Will Drive Efficiency in Vaccine Manufacturing
4.5 Paediatric Vaccines Market Overview
4.6 Adult Prophylactic Vaccines Market Overview
4.7 Influenza Vaccines Market Overview
4.8 Therapeutic Vaccines Market Overview
5. The Global Vaccine Contract Manufacturing 2019-2029
5.1 Outsourcing in the Pharmaceutical and Biotechnology Industry
5.1.1 Reasons to Outsource
5.1.2 Benefits of Outsourcing
5.1.3 The Challenges in Outsourcing Vaccine Manufacturing
5.1.4 Why Should Companies Outsource Vaccine Manufacturing?
5.1.5 Strategic Outsourcing Vs Tactical Outsourcing
5.1.6 Virtual Companies
5.2 Contract Manufacturing Organisations (CMOs)
5.2.1 Manufacturing Services Offered by CMOs
5.2.2 Vaccine Manufacturing Activities Typically Outsourced
5.3 The Vaccine Contract Manufacturing Market: Overall Revenue Forecast 2019-2029
5.4 Contract Manufacturing Market for Vaccines 2018-2029
5.4.1 Market Size for Contract Manufacturing of Vaccines 2018
5.4.2 Vaccine Contract Manufacturing Market Forecast 2019-2029
6. Vaccine Contract Manufacturing Market by Vaccine Type, 2019-2029
6.1 Paediatric Vaccines
6.2 Adult Vaccines
6.3 Influenza Vaccines
6.4 Therapeutic Vaccines
7. Vaccine Contract Manufacturing Market by Workflow, 2019-2029
7.1 Downstream Processing
7.1.1 Fill & Finish Operations
7.1.2 Analytical & QC Studies
7.1.3 Packaging
7.2 Upstream Processing
7.2.1 Mammalian Expression Systems
7.2.2 Bacterial Expression Systems
7.2.3 Yeast Expression Systems
7.2.4 Baculovirus/Insect Expression Systems
7.2.5 Other Upstream Processing
8. Leading National Markets for Vaccine Contract Manufacturing, 2019-2029
8.1 Leading National Markets for Vaccine Contract Manufacturing
8.2 North America Vaccine Contract Manufacturing Market, 2018-2029
8.2.1 US Vaccine Contract Manufacturing Market Forecast, 2018-2029
8.2.2 Canada Vaccine Contract Manufacturing Market Forecast, 2018-2029
8.3 The Europe Vaccine Contract Manufacturing Market, 2018-2029
8.3.1 Germany Vaccine Contract Manufacturing Market, 2016-2028
8.3.2 UK Vaccine Contract Manufacturing Market, 2018-2029
8.3.3 French Vaccine Contract Manufacturing Market, 2018-2029
8.3.4 Italy Vaccine Contract Manufacturing Market, 2018-2029
8.3.5 Spain Vaccine Contract Manufacturing Market, 2018-2029
8.4 Asia-Pacific Vaccine Contract Manufacturing Market, 2018-2029
8.4.1 Japan Vaccine Contract Manufacturing Market, 2018-2029
8.4.2 China Vaccine Contract Manufacturing Market, 2018-2029
8.4.3 India Vaccine Contract Manufacturing Market, 2018-2029
8.5 Rest of the World Vaccine Contract Manufacturing Market, 2018-2029
8.5.1 Brazil Vaccine Contract Manufacturing Market, 2018-2029
8.5.2 Mexico Vaccine Contract Manufacturing Market, 2018-2029
8.5.3 Russia Vaccine Contract Manufacturing Market, 2018-2029
8.5.4 South Africa Vaccine Contract Manufacturing Market, 2019-2029
9. Leading Vaccine Contract Manufacturing Companies, 2018-2029
9.1 Leading Vaccine Contract Manufacturing Organisations
9.2 Baxter BioPharma Solutions
9.2.1 Recent Financial Performance
9.2.2 Key Developments
9.3 Boehringer Ingelheim
9.3.1 Recent Financial Performance
9.3.2 Ben Venue Laboratories
9.3.3 Manufacturing Deals 2011-2017
9.4 Catalent
9.4.1 Recent Financial Performance
9.4.2 Catalent: Financial Performance by Segment, 2011-2016
9.4.3 Catalent Injectable Vaccines
9.4.4 Catalent: Zydis Technology
9.4.5 Regional Market Expansion Strategy
9.5 Charles River Laboratories
9.5.1 Recent Financial Performance, 2011-2017
9.5.2 Financial Performance by Segment, 2012-2018
9.5.3 Vaccine Manufacturing Services
9.5.4 Charles River Avian Vaccine Services
9.5.5 Vaccine Manufacturing Expansion
9.5.6 Outlook and Early Stage Restructuring
9.5.7 Partnerships
9.5.7.1 Partnership with AstraZeneca
9.5.7.2 Partnership with Batavia
9.6 IDT Biologika GmbH
9.7 Lonza
9.7.1 Recent Financial Performance
9.7.2 Manufacturing Division Restructuring
9.8 Meridian Life Science
9.8.1 Recent Financial Performance, 2012-2018
9.9 Sigma-Aldrich Fine Chemicals (SAFC) (Merck KGaA)
9.10 SynCo Bio Partners
9.10.1 Recent Developments
9.10.1.1 Expansion of Facilities
9.10.1.2 FDA Approval of Partner Application
9.11 AbbVie Contract Manufacturing
9.11.1 AbbVie Offers Full-Service Contract Manufacturing
9.11.2 Recent Financial Performance: Revenue 2012-2017
9.11.3 Strategic Developments 2017-2018
9.12 Evonik Degussa
9.12.1 API and Drug Delivery Services
9.13 Vetter Pharmaceutical
9.13.1 Financial Performance, 2013-2017
9.13.2 Regional Expansion
9.14 Pfizer CentreOne
9.14.1 Financial Performance, 2013-2018
9.14.2 Strategic Developments 2017-2018
9.15 Nipro Corporation
9.15.1 Contract Manufacturing Capabilities
10. Global Vaccine Contract Manufacturing Market: World Market Trends 2018-2029
10.1 Vaccine Contract Manufacturing Industry Trends
10.2 Strengths
10.2.1 Many Companies Cannot Afford In-house Capabilities
10.2.2 Outsourcing Improves Time to Market
10.2.3 Manufacturers Get Access to Specialised Technologies
10.2.4 Shift Towards Emerging Markets as Favourable Outsourcing Destinations
10.3 Weaknesses
10.3.1 Mass Vaccine Manufacturing Kept In-house
10.3.2 A Highly-Fragmented Vaccine Contract Manufacturing Market
10.3.3 An Unpredictable Supply and Demand Business Model
10.4 Opportunities
10.4.1 Many Vaccines in the Product Pipeline
10.4.2 Emerging Market's Growing Demand for Vaccines
10.4.2.1 Dynamic Change: Emerging Markets are Major Vaccine Developers
10.4.3 Changing World Demographics
10.5 Threats
10.5.1 Post Recession: Biotech Suffer from Severe Cuts in Capital Funding
10.5.2 The Public are Slow to Accept Novel Technologies
10.5.3 Perception of Risk by the Original Vaccine Manufacturers
11. Conclusion
11.1 Overview
11.2 Regulatory and Quality Standards Create High Barriers of Entry
11.3 Emerging Markets Will Show Stronger Growth
Appendices
Associated Visiongain Reports
Visiongain Report Sales Order Form
About Visiongain
Visiongain report evaluation form
List of Tables
Table 2.1 Timeline of Key Events in Vaccine Development, c.1000 AD - Present
Table 3.1 Vaccine Development Pipeline Using Crucell's AdVac Technology
Table 3.2 Benefits and Drawbacks of Using Disposable Technology for Vaccine Production
Table 3.3 Companies Providing Disposable Biomanufacturing Platforms/Systems
Table 3.4 Some Leading Pre-Filled Syringe Vaccine Products
Table 3.5 Prominent Lyophilised Vaccines
Table 3.6 Examples of Serum-Free Media for Vaccine Manufacturing
Table 4.1 The Global Vaccine Market Forecast: Revenue ($bn), AGR (%) and CAGR (%) 2018-2029
Table 4.2 The Global Vaccine Market: Revenue ($bn) and Market Share by Submarket (%), 2018-2019
Table 5.1 The Global Vaccine Contract Manufacturing Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 6.1 Global Paediatric Vaccines Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 6.2 Global Adult Vaccines Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 6.3 Global Influenza Vaccines Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 6.4 Global Therapeutic Vaccines Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 7.1 Global Downstream Processing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 7.2 Global Fill & Finish Operations Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 7.3 Global Analytical & QC Studies Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 7.4 Global Packaging Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 7.5 Global Upstream Processing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 7.6 Global Mammalian Expression Systems Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 7.7 Global Bacterial Expression Systems Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 7.8 Global Yeast Expression Systems Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 7.9 Global Baculovirus/Insect Expression Systems Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 7.10 Global Other Upstream Processing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.1 Leading National Vaccine Contract Manufacturing Markets Forecast: Revenue ($m) and Market Share (%), 2018-2019
Table 8.2 North America Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.3 North America Vaccine Contract Manufacturing Market, By Vaccine Type Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.4 North America Vaccine Contract Manufacturing Market by Workflow Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.5 North America Downstream Processing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.6 North America Upstream Processing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.7 US Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.8 Canada Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.9 Europe Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.10 Europe Vaccine Contract Manufacturing Market by Vaccine Type Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.11 Europe Vaccine Contract Manufacturing Market by Workflow Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.12 Europe Downstream Processing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.13 Europe Upstream Processing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.14 Germany Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.15 UK Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.16 France Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.17 Italy Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.18 Spain Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.19 Asia-Pacific Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.20 Asia-Pacific Vaccine Contract Manufacturing Market by Vaccine Type Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.21 Asia-Pacific Vaccine Contract Manufacturing Marke by Workflow Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.22 Asia Pacific Downstream Processing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.23 Asia Pacific Upstream Processing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.24 Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.25 Chinese Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.26 Indian Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.27 RoW Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.28 RoW Vaccine Contract Manufacturing Market by Vaccine Type Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.29 RoW Vaccine Contract Manufacturing Market by Workflow Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.30 RoW Downstream Processing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.31 RoW Upstream Processing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.32 Brazilian Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.33 Mexican Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.34 Russian Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.35 South Africa Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 9.1 Baxter BioPharma Solutions Overview
Table 9.2 Baxter BioPharma Manufacturing: Revenue ($m), Annual Growth (%), CAGR (%), 2013-2018
Table 9.3 Boehringer Ingelheim Biopharmaceuticals Overview
Table 9.4 Boehringer Ingelheim: Biopharmaceuticals Revenue ($m) and Annual Growth Rate (%), 2012-2018
Table 9.5 Catalent Overview
Table 9.6 Catalent: Revenue($m) and AGR (%), 2012-2018
Table 9.7 Charles River Laboratories: Revenue ($m) and AGR (%), 2012-2018
Table 9.8 Charles River Laboratories: Newly Revised Reportable Segments
Table 9.9 Charles River Laboratories: cGMP Vaccine Manufacturing and Testing Capabilities
Table 9.10 Lonza Custom Manufacturing: Revenue ($m) and AGR (%), 2010-2016
Table 9.11 Meridian Bioscience: Revenue ($m), AGR (%), 2012-2018
Table 9.12 SynCo Bio Partners Capabilities
Table 9.13 AbbVie Contract Manufacturing: Details, 2017
Table 9.14 Evonik Degussa Details, 2018
Table 9.15 Vetter Details, 2017
Table 9.16 Vetter Pharmaceutical Manufacturing: Revenue ($m), Annual Growth Rate (%), CAGR (%), 2013-2017
Table 9.17 Pfizer CentreOne Details, 2018
Table 9.18 Pfizer CentreSource: Revenue ($m), Annual Growth Rate (%), CAGR (%), 2013-2018
Table 9.19 Nipro Pharma Overview
Table 9.20 Nipro Pharmaceutical Contract Manufacturing Capabilities: 2011-2017
Table 10.1 SWOT Analysis of the Vaccine Contract Manufacturing Market
List of Figures
Figure 3.1 Influenza Vaccine Production Using a Cell-Based Manufacturing Method
Figure 3.2 Medicago's Product Pipeline
Figure 3.3 Novavax' Insect Egg-Based Vaccine Production Process
Figure 3.4 Pre-filled Syringes Market: Drivers and Restraints, 2019-2029
Figure 4.1 The Global Vaccine Market Forecast: Revenue ($bn), AGR (%) 2018-2029
Figure 4.2 The Global Vaccine Market: Market Share by Submarket (%), 2018
Figure 5.1 Selected Tasks Outsourced in the Pharmaceutical and Biotech Industry
Figure 5.2 Global Vaccine Contract Manufacturing Forecast: Revenue ($m), 2019, 2023 and 2029
Figure 5.3 The Global Vaccine Contract Manufacturing Forecast: Revenue ($Mn) and AGR (%), 2018-2029
Figure 6.1 Global Vaccine Contract Manufacturing Forecast by Vaccine Type: Revenue ($m), 2018-2029
Figure 6.2 Global Vaccine Contract Manufacturing Forecast by Vaccine Type: Market Share (%), 2018-2029
Figure 6.3 Global Paediatric Vaccines Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 6.4 Global Adult Vaccines Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 6.5 Global Influenza Vaccines Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 6.6 Global Therapeutic Vaccines Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 7.1 Global Vaccine Contract Manufacturing Forecast by Workflow: Revenue ($m), 2018-2029
Figure 7.2 Global Vaccine Contract Manufacturing Forecast, By Workflow: Market Share (%), 2018-2029
Figure 7.3 Global Downstream Processing Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 7.4 Global Fill & Finish Operations Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 7.5 Global Analytical & QC Studies Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 7.6 Global Packaging Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 7.7 Global Upstream Processing Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 7.8 Global Mammalian Expression Systems Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 7.9 Global Bacterial Expression Systems Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 7.10 Global Yeast Expression Systems Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 7.11 Global Baculovirus/Insect Expression Systems Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 7.12 Global Other Upstream Processing Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 8.1The Leading National Vaccine Contract Manufacturing: Market Share (%) by Region, 2018
Figure 8.2 North America Vaccine Contract Manufacturing: Market Share (%) by Region, 2018-2029
Figure 8.3 U.S. Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 8.4 Canada Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 8.5 Europe Vaccine Contract Manufacturing: Market Share (%) by Region, 2018-2029
Figure 8.6 Germany Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 8.7 UK Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 8.8 France Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 8.9 Italy Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 8.10 Spain Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 8.11 Asia-Pacific Vaccine Contract Manufacturing: Market Share (%) by Region, 2018-2029
Figure 8.12 Japanese Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 8.13 Chinese Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 8.14 Indian Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 8.15 RoW Vaccine Contract Manufacturing: Market Share (%) by Region, 2018-2029
Figure 8.16 Brazilian Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 8.17 Mexican Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 8.18 Russia Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 8.19 South Africa Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 9.1 Baxter BioPharma Manufacturing: Revenue ($m), 2013-2018
Figure 9.2 Boehringer Ingelheim: Biopharmaceuticals Revenue ($m) and Annual Growth Rate (%), 2012-2018
Figure 9.3 Catalent: Revenue ($m) and AGR (%), 2012-2018
Figure 9.4 Catalent Financial Performance by Division: Revenue ($m), 2013-2018
Figure 9.5 Charles River Laboratories: Revenue ($m) and AGR (%), 2012-2018
Figure 9.6 Lonza Custom Manufacturing: Revenue ($m) and AGR (%), 2010-2016
Figure 9.7 Meridian Bioscience: Revenue ($m), and AGR (%), 2012-2018
Figure 9.8 Nipro Pharmaceutical Contract Manufacturing Capabilities: Orally Administered Drugs, Injectables, External Preparations, 2011-2017
Figure 10.1 Drivers and Restraints for the Vaccine Contract Manufacturing Sector
Figure 11.1 The Global Vaccine Contract Manufacturing Market: Market Share by Region (%), 2018, 2023, 2029
Figure 11.2 The Global Vaccine Contract Manufacturing: National Market Share (%), 2018 - 2029
